Investor Overview

NASDAQ: XBIT0.002.80Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
DateTitle 
09/20/18XBiotech Announces Addition of Top Dermatologist and Researcher Dr. Alice Gottlieb to its TeamPrinter Friendly Version
09/13/18XBiotech Announces Completion and Positive Interim Findings for Initial Cohort in Bermekimab Pilot Study in Atopic DermatitisPrinter Friendly Version
09/12/18XBiotech Announces Addition of World Leading Cardiologist Dr. Peter Libby to its Scientific Advisory BoardPrinter Friendly Version

Read more »

Upcoming Events

There are currently no events scheduled.

Read more »